Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Oppenheimer Initiates Coverage On Zura Bio with Outperform Rating, Announces Price Target of $17

Author: Benzinga Newsdesk | August 25, 2023 03:07am
Oppenheimer analyst Justin Kim initiates coverage on Zura Bio (NASDAQ:ZURA) with a Outperform rating and announces Price Target of $17.

Posted In: ZURA